Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer

X
Trial Profile

Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 04 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary) ; Zirconium-89 cetuximab (Primary) ; Panitumumab
  • Indications Adenocarcinoma; Colorectal cancer; Liver metastases
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms IMPACT-CRC
  • Most Recent Events

    • 04 Jun 2024 Results assessing the predictive performance of early evaluation of metabolic rate with [18F]FDG PET/CT and baseline and after 1 intravenous anti-EGFR mAb administration to distinguish patients with and without clinical benefit, presented at the 60th Annual Meeting of the American Society of Clinical Oncology.
    • 07 Mar 2021 Status changed from recruiting to discontinued.
    • 05 Oct 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top